Augmentation of coronary flow reserve in patients with type 2 diabetes mellitus: Comparison between angiotensin-converting enzyme inhibitor and angiotensin receptor blocker

被引：0
|
作者：
Kawata, T
Toyoda, T
Hasegawa, R
Teramoto, K
Sekine, T
Maekawa, S
Lee, K
Uchida, D
Himi, T
Kuwabara, Y
机构：
[1] Chiba Univ, Grad Sch Med, Chiba, Japan
[2] Kimitsu Chuo Hosp, Kisarazu, Japan
来源：
CIRCULATION | 2004年 / 110卷 / 17期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2002
引用
收藏
页码：425 / 425
页数：1
相关论文
共 50 条
  • [1] Effect on coronary flow velocity reserve in patients with type 2 diabetes mellitus: Comparison between angiotensin-converting enzyme inhibitor and angiotensin II type 1 receptor antagonist
    Kawata, T
    Daimon, M
    Hasegawa, R
    Teramoto, K
    Toyoda, T
    Sekine, T
    Yamamoto, K
    Uchida, D
    Himi, T
    Yoshida, K
    Komuro, I
    AMERICAN HEART JOURNAL, 2006, 151 (04) : 798.e9 - 798.e15
  • [2] Comparison between angiotensin-converting enzyme inhibitor and angiotensin receptor blocker after percutaneous coronary intervention
    Ann, Soe Hee
    Strauss, Martin H.
    Park, Gyung-Min
    Han, Seungbong
    Yang, Yujin
    Kim, Yong-Giun
    Won, Ki-Bum
    Kim, Shin-Jae
    Lee, Sang-Gon
    Cho, Young-Rak
    Kim, Dae-Won
    Park, Mahn-Won
    Her, Sung Ho
    Lee, Seung-Whan
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2020, 306 : 35 - 41
  • [3] Angiotensin converting enzyme inhibitor or angiotensin II receptor blocker for the prevention of type 2 diabetes mellitus?
    Chen, Ching-Chu
    Chiang, An-Na
    Hsieh, Min-Huang
    DIABETES RESEARCH AND CLINICAL PRACTICE, 2010, 90 (02) : E25 - E26
  • [4] Clinical Value of Angiotensin-converting Enzyme Inhibitor and Angiotensin Receptor Blocker in the Patients of Coronary Artery Disease
    Abe, Daisuke
    Sato, Akira
    Misaki, Masako
    Takeyasu, Noriyuki
    Hoshi, Tomoya
    Aonuma, Kazutaka
    CIRCULATION, 2013, 128 (22)
  • [5] Angiotensin Receptor Blockers and Angiotensin-Converting Enzyme Inhibitors for the Treatment of Hypertensive Patients With Type 2 Diabetes Mellitus
    Kawada, Tomoyuki
    CANADIAN JOURNAL OF DIABETES, 2020, 44 (01) : 4 - 4
  • [6] Paradoxical pressor response with angiotensin-converting enzyme inhibitor and angiotensin receptor blocker
    Sabitha, P.
    Adhikari, Prabha M.
    AUSTRALASIAN MEDICAL JOURNAL, 2011, 4 (07): : 364 - +
  • [7] Effects of combination therapy of an angiotensin-converting enzyme inhibitor and an angiotensin receptor blocker
    Idrizi, A
    Gjata, M
    Barbullushi, M
    Koroshi, A
    Tase, M
    Sadiku, E
    Hoti, K
    JOURNAL OF HYPERTENSION, 2005, 23 : S398 - S398
  • [8] Angiotensin converting enzyme inhibition improves impaired coronary flow reserve in type 2 diabetes mellitus
    Kawata, T
    Daimon, M
    Hasegawa, R
    Teramoto, K
    Toyoda, T
    Sekine, T
    Komuro, I
    Yamamoto, K
    Uchida, D
    Himi, T
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 41 (06) : 154A - 154A
  • [9] Angiotensin-converting enzyme inhibitor and angiotensin receptor blocker use and outcomes in patients with colorectal cancer
    Tuazon, Sherilyn Alvaran
    King, Gantry Teng
    Cruz, Joanna Sta.
    Chae, Young K.
    Koc, Jean B. Ong Klan
    Hegarty, Sarah
    Leighton, John Charles
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [10] Effect of angiotensin-converting enzyme inhibitor on serum asymmetric dimethylarginine and coronary circulation in patients with type 2 diabetes mellitus
    Kawata, Takayuki
    Daimon, Masao
    Hasegawa, Rei
    Teramoto, Kiyomi
    Toyoda, Tomohiko
    Sekine, Tai
    Yamamoto, Kyohei
    Uchida, Daigaku
    Himi, Toshiharu
    Yoshida, Katsuya
    Komuro, Issei
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 2009, 132 (02) : 286 - 288
12345